Quebecor (TSE:QBR – Free Report) – Investment analysts at Cormark lowered their FY2024 earnings per share (EPS) estimates for Quebecor in a research report issued to clients and investors on Thursday, October 31st. Cormark analyst D. Mcfadgen now anticipates that the company will earn $3.28 per share for the year, down from their prior estimate of $3.29.
Separately, Scotiabank downgraded Quebecor from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 10th.
Quebecor Price Performance
Quebecor (TSE:QBR – Get Free Report) last issued its quarterly earnings results on Thursday, August 8th. The company reported C$0.89 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of C$0.84 by C$0.05. The business had revenue of C$1.39 billion for the quarter, compared to analysts’ expectations of C$1.43 billion.
Quebecor Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 17th. Investors of record on Friday, August 23rd were given a dividend of $0.325 per share. The ex-dividend date was Friday, August 23rd. This represents a $1.30 dividend on an annualized basis and a yield of ?.
About Quebecor
Quebecor Inc, together with its subsidiaries, operates in the telecommunications, media, and sports and entertainment businesses in Canada. Its Telecommunications segment offers television distribution, Internet access, wireline and mobile telephony, business solutions, and over-the-top video services; and Helix, a technology platform that provides entertainment and home management with features, including voice remote, ultra-intelligent Wi-Fi, and support for home automation.
Read More
- Five stocks we like better than Quebecor
- 3 Best Fintech Stocks for a Portfolio Boost
- Intel: Is Now the Time to Be Brave?
- Stock Market Sectors: What Are They and How Many Are There?
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- How to Invest in Biotech Stocks
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Quebecor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quebecor and related companies with MarketBeat.com's FREE daily email newsletter.